Excedrin Rapid Reliefacetaminophen

According to the FDA label: Uses temporarily relieves minor aches and pains due to: headache the common cold backache minor pain of arthritis toothache muscular aches premenstrual and menstrual cramps temporarily reduces fever

253,914 adverse event reports submitted to the FDA (1998–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Excedrin Rapid Relief in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Excedrin Rapid Relief adverse event reports by reporter sex
SexReports
Female138,545
Male82,292
Unknown522

By Age Group

View age group data as a table
Excedrin Rapid Relief adverse event reports by reporter age group
Age groupReports
0-1713,815
18-3421,460
35-4932,432
50-6444,297
65-7433,196
75+32,282

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Excedrin Rapid Relief. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Excedrin Rapid Relief adverse event reports by reported outcome
OutcomeReports
Other Serious133,898
Hospitalization111,837
Death49,161
Non-Serious36,113
Life-Threatening21,149
Disability11,666

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Excedrin Rapid Relief. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Excedrin Rapid Relief adverse event reports by year
YearReports
19981
19994
20011
20021
20034
20042,660
20052,692
20063,160
20072,569
20083,880
20093,008
20103,792
20118,063
20128,130
20133,488
20144,207
20156,505
20169,484
20179,039
201810,017
201913,187
202020,041
202120,311
202227,381
202328,136
202428,830
202528,250
2026 (partial)7,073

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Excedrin Rapid Relief

In FDA adverse event reports that mention Excedrin Rapid Relief, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026